Quality-of-life findings in patients with midgut neuroendocrine tumors: Results of the NETTER-1 phase III trial. Strosberg, J. R., Wolin, E. M., Chasen, B., Kulke, M. H., Bushnell, D. L., Caplin, M. E., Baum, R. P., Kunz, P. L., Hobday, T. J., Hendifar, A., Oberg, K. E., Sierra, M., Kwekkeboom, D. J., Ruszniewski, P. B., Krenning, E. AMER SOC CLINICAL ONCOLOGY. 2017

View details for Web of Science ID 000443281700338